Produkty 919347-16-3

CAS 919347-16-3 występuje w naszej ofercie pod nazwami: 5-Morpholinomethylpyridine-3-boronic acid pinacol ester, 95%, 4-((5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl)methyl)morpholine, 95-<97%, 4-((5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl)methyl)morpholine, ≥97-<99%. Oferty producentów: Combi-blocks, Hoffman Fine Chemicals. Dostępne opakowania: 100mg, 1g, 250mg, 2,5g, 5g, 10g, 25g.

5-Morpholinomethylpyridine-3-boronic acid pinacol ester, 95%
Combi-blocks
  • opakowanie: 100mg, 1g, 250mg
  • Warianty: 3
Zobacz produkt
4-((5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl)methyl)morpholine, 95-<97%
Hoffman Fine Chemicals
  • opakowanie: 1g, 2,5g, 5g, 10g
  • Warianty: 5
od 4678,30
Zobacz produkt
4-((5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl)methyl)morpholine, ≥97-<99%
Hoffman Fine Chemicals
  • opakowanie: 1g, 2,5g, 5g, 10g
  • Warianty: 5
od 5992,58
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

4-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]methyl]morpholine (CAS 919347-16-3) to związek chemiczny o wzorze sumarycznym C16H25BN2O3 i masie molowej 304.2 g/mol. Nazwa systematyczna IUPAC: 4-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]methyl]morpholine. InChIKey: IMKOBBHEFQOPFH-UHFFFAOYSA-N.

Dane identyfikacyjne
Wzór sumarycznyC16H25BN2O3
Masa molowa304.2 g/mol
Nazwa IUPAC4-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]methyl]morpholine
InChIKeyIMKOBBHEFQOPFH-UHFFFAOYSA-N
SMILESB1(OC(C(O1)(C)C)(C)C)C2=CC(=CN=C2)CN3CCOCC3

Dane obliczone przez PubChem (NCBI)

Synonimy: 5-Morpholinomethylpyridine-3-boronic acid pinacol ester, IMKOBBHEFQOPFH-UHFFFAOYSA-N, s11439, 4-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridyl]methyl]morpholine
Izomery (ten sam wzór sumaryczny)
N-(oxolan-2-ylmethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine C16H25BN2O3
1-propyl-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea C16H25BN2O3
4-[3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]morpholine C16H25BN2O3
4-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]methyl]morpholine C16H25BN2O3
1-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]piperidin-4-ol C16H25BN2O3
N,N-diethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2-carboxamide C16H25BN2O3
2-(dimethylamino)-N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide C16H25BN2O3
N-tert-butyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-3-carboxamide C16H25BN2O3
2,2-dimethyl-N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]propanamide C16H25BN2O3
1-propan-2-yl-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea C16H25BN2O3
1-propan-2-yl-3-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea C16H25BN2O3
1-ethyl-3-[2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea C16H25BN2O3